Financial reports
10-K
2023 FY
Annual report
20 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
7 Feb 24
8-K
Other Events
16 Jan 24
8-K
Receives $2 Million Pre-Closing Collaboration and Option Fee
14 Nov 23
8-K
Unregistered Sales of Equity Securities
29 Sep 23
8-K
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
16 Aug 23
8-K
Unregistered Sales of Equity Securities
23 Jun 23
8-K
Changes in Registrant's Certifying Accountant
12 May 23
8-K
Regulation FD Disclosure
11 Apr 23
8-K
Unregistered Sales of Equity Securities
4 Apr 23
8-K
Regulation FD Disclosure
22 Mar 23
Registration and prospectus
D
$3.50 mm in equity / options, sold $925.00 k, 3 investors
6 Oct 22
RW
Registration withdrawal request
16 May 22
S-1/A
IPO registration (amended)
4 Apr 22
S-1/A
IPO registration (amended)
1 Apr 22
8-A12B
Registration of securities on exchange
28 Mar 22
S-1/A
IPO registration (amended)
23 Mar 22
S-1/A
IPO registration (amended)
10 Mar 22
S-1
IPO registration
17 Dec 21
D
$1M in debt / options, sold $555K, 6 investors
15 Nov 21
D
$2.5M in equity / options, sold $2.5M, 29 investors
5 Feb 21
Proxies
DEFM14C
Information related to merger
11 Apr 24
PREM14C
Preliminary information related to merger
1 Apr 24
DEF 14C
Information statement
6 Jan 22
PRE 14C
Preliminary information
17 Dec 21
DEF 14A
Definitive proxy
3 Jan 20
PRER14A
Preliminary revised proxy
6 Dec 19
PRE 14A
Preliminary proxy
5 Nov 19
PRE 14A
Preliminary proxy
28 Aug 17
DEF 14C
Information statement
2 Jun 15
PRE 14C
Preliminary information
22 May 15
Other
CERT
Certification of approval for exchange listing
29 Mar 22
UPLOAD
Letter from SEC
13 Dec 19
CORRESP
Correspondence with SEC
5 Dec 19
UPLOAD
Letter from SEC
20 Nov 19
UPLOAD
Letter from SEC
1 Mar 17
UPLOAD
Letter from SEC
21 Dec 16
UPLOAD
Letter from SEC
5 Jun 14
UPLOAD
Letter from SEC
3 Jun 14
UPLOAD
Letter from SEC
5 May 14
UPLOAD
Letter from SEC
18 Mar 14
Ownership
SC 13D/A
Checkmate Strategic Capital 2, LLC
20 Feb 24
5
Charles Thomas Paschall
20 Feb 24
SC 13G/A
Strategic Planning Assets Ltd
20 Feb 24
SC 13G/A
GSB Holdings, Inc.
15 Feb 24
4/A
Douglas R Baum
14 Feb 24
4/A
Christopher M. Nelson
14 Feb 24
4/A
Jr. Charles J Link
14 Feb 24
4
Douglas R Baum
13 Feb 24
4
Christopher M. Nelson
13 Feb 24
4
Adam King
29 Jun 23